Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece
NCT ID: NCT01282866
Last Updated: 2016-10-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2009-06-30
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of LightSheer Duet 805nm HS Handpiece
NCT01801202
Evaluation of the LightSheer HS Hand Piece as Compared to the LightSheer ET Hand Piece for the Intended Use of Hair Removal and Permanent Hair Reduction
NCT00657085
Combined 755nm Alexandrite Laser With Bipolar RF for Hair Reduction
NCT02465788
Long Term Efficiency of the Hair2Go Device
NCT01529931
The Effect of Laser Hair Removal on Permanent Hair Reduction
NCT00279643
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HS treatment
Treatment with HS handpiece
LightSheer Duet
LightSheer Duet HS handpiece
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LightSheer Duet
LightSheer Duet HS handpiece
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Having at least one suitable treatment area for hair removal with brown hair;
3. Able and willing to comply with the treatment/follow-up schedule and requirements;
4. Able to read, understand and provide written Informed Consent.
5. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to market preference test enrollment and throughout the course of the study treatment.
Exclusion Criteria
2. Use of oral isotretinoin (Accutane®) within 6 months
3. Prior skin treatment with laser or other devices on the same treated areas prior to study enrollment or during the course of the study;
4. History of keloid formation or poor wound healing in a previously injured skin area;
5. Significant skin conditions affecting treated area or inflammatory skin conditions;
6. Open laceration, abrasion, active cold sores or herpes sores on area to be treated;
7. History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications;
8. Having a history of bleeding disorder or taking anticoagulation medications before the washout period, per the package insert, and at the physician's discretion;
9. Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the area to be treated, personal history of melanoma;
10. Significant concurrent illness, such as diabetes, lupus, epilepsy or cardiac disorders, which might be aggravated as a result of treatment;
11. Unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray or cream, during the course of the evaluation;
12. Tattoos in the treatment areas;
13. Dysplastic nevi in the treatment areas;
14. Participation in a study of another device or drug within 3 month prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria;
15. Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;
16. Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study;
17. Allergy or history of an allergy to any topical anesthetic used;
18. Pregnant, expectation of pregnancy, postpartum (\<3 months) or nursing (\<6 weeks);
19. History of livedo reticularis, an autoimmune vascular disease;
20. Hypersensitivity at the treatment site to any agents, solutions, or gel used in the treatment (applies to ET handpiece only), if no alternative exists;
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lumenis Be Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laser & Skin Surgery Medical Group Inc
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LUM- ABU-LSDuet-08-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.